I den spontane, postmarketing database har der været rapporter om uro, hæmothorax, hyperhidrose, forøget legemstemperatur og forøget behov for katekolaminer til at understøtte blodtrykket (ordret term: forøget behov for katekolaminer) i behandlingsforløbet.
In the spontaneous, postmarketing database, there have been reports of restlessness, haemothorax, hyperhydrosis, increased body temperature and increased need of catecholamines to support blood pressure (verbatim term: increased need for catecholamines) in the course of the treatment.